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A B S T R A C T
Objective: Hereditary hearing impairment is a genetically heterogeneous disorder. In spite of this,
mutations in the GJB2 gene, encoding connexin 26 (Cx26), are a major cause of nonsyndromic recessive
hearing loss in many countries and are largely dependent on ethnic groups. The purpose of our study was
to characterize the type and prevalence of GJB2 mutations among Azeri population of Iran.
Methods: Fifty families presenting autosomal recessive nonsyndromic hearing loss from Ardabil
province of Iran were studied for mutations in GJB2 gene. All DNA samples were screened for c.35delG
mutation by ARMS PCR. Samples from patients who were normal for c.35delG were analyzed for the
other variations in GJB2 by direct sequencing. In the absence of mutation detection, GJB6 was screened
for the del(GJB6-D13S1830) and del(GJB6-D13S1854).
Result: Thirteen families demonstrated alteration in the Cx26 (26%). The 35delG mutation was the most
common one, accounting for 69.2% (9 out of 13 families). All the detected families were homozygous for
this mutation. Two families were homozygous for delE120 and 299–300delAT mutations. We also
identiﬁed a novel mutation: c.463–464 delTA in 2 families resulting in a frame shift mutation.
Conclusion: Our results suggest that c.35delG mutation in the GJB2 gene is the most important cause of
GJB2 related deafness in Iranian Azeri population.
 2011 Elsevier Ireland Ltd. All rights reserved.
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jo ur n al ho m ep ag e: ww w.els evier . c om / lo cat e/ i jp o r l1. Introduction
Hearing loss is the most common sensorineural disorder in
humans affecting about 1 in 1000 newborns. The majority of
hereditary hearing loss is nonsyndromic and presents autosomal
recessive pattern of inheritance (70%), the remaining are autoso-
mal-dominant (20%), Xlinked (1%), and mitochondrial (<1%) forms
[1]. So far, over 95 loci have been mapped and about 40 genes
responsible for ARNSHL have been identiﬁed [2]. Although hearing
loss is very heterogeneous, in some populations up to 50% of cases
of prelingual non-syndromic sensorineural hearing loss (NSSHL)
are due to mutations in a single gene, GJB2 (MIM#121011), which
is located at DFNB1 locus on chromosome 13q12 and encodes* Corresponding author at: Genetic Research Centre, National Prenatal Reference
Laboratory, University of Social Welfare and Rehabilitation Sciences, Koodakyar St,
Daneshjoo Blvd, Evin, Tehran 1985713834, Iran. Tel.: +98 21 22180138;
fax: +98 21 22180138.
E-mail address: hnajm12@yahoo.com (H. Najmabadi).
1 Joint ﬁrst authors.
0165-5876/$ – see front matter  2011 Elsevier Ireland Ltd. All rights reserved.
doi:10.1016/j.ijporl.2011.11.019connexin 26 protein (Cx26). Cx26 belongs to a large family of gap
junction proteins which contribute in intracellular communica-
tion. In particular, this protein has an important role in recycling
potassium ions in the inner ear [3].
One of the important mutations in GJB2 is c.35delG, which
account for the majority of GJB2 related deafness in the Caucasians
population [4,5]. Over 100 other mutations have been reported in
the GJB2 gene [6], of which 167delT, 235delC, V37I, W24X and
R143W are the most common ones in Ashkenazi Jews, Japanese,
Taiwan, Indian, and Ghanaian populations, respectively, which
indicate that mutations in this gene are ethnic-speciﬁc [7–13].
Despite such diversity, the combined frequency of all GJB2
mutations in different population is high enough to make mutation
analysis of this gene a clinically useful, and therefore widely
available, genetic test.
A second gap-junction gene, GJB6, also localizes to the DFNB1
interval. Two large deletion del(GJB6-D13S1830) and del(GJB6-
D13S1854) has been reported to cause ARNSHL in homozygote or
compound heterozygote individuals carrying deafness-causing
allele variants of the GJB2 [14].
Table 1
Genetic variants in the GJB2 gene identiﬁed in this study with percentage of
consanguinity.
Genotype Frequency Consanguinity
35delG/35delG 9/50 6/9a
463–464delTA/463–464delTA 2/50 Consanguineous
delE120/delE120 1/50 Consanguineous
299–300delAT/299–300delAT 1/50 Non consanguineous
A171T/WT 1/50 Consanguineous
V27I+E114G/WT 1/50 Consanguineous
a 6 out of nine mutated families have consanguineous marriage.
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in Iranian population to identify the mutation spectrum and
prevalence of GJB2 gene mutations [15,16]. In this study, we
attempt to determine the prevalence and spectrum of GJB2
mutations in the Azeri hearing loss population in Ardabil province
in northwest of Iran. Ardabil province is bound to the north by
Azerbaijan, to the east by the Caspian Sea and to the west by east-
Azerbaijan province. Consanguinity and assortative mating are
very common in this population [17].
2. Materials and methods
2.1. Patients
A total of 50 families from Ardebil province were investigat-
ed. To be included in this study, families had to meet the
following criteria: (1) hearing loss is documented by audiologic
testing; (2) hearing loss in the absence of other clinical features;
(3) a pedigree structure consistent with autosomal recessive
inheritance; (4) two or more affected family members. A
relatively high level of consanguinity (80%) was seen in the
studied families. Puretone audiometry at 125–8000 Hz was
performed for affected subjects and all have severe to profound
hearing loss.
Informed consent was obtained from all family members who
participated in the study and then blood samples were obtained
from all family members. This study had been approved by the
ethics committee of the Genetics Research Center, University of
Social Welfare and Rehabilitation Sciences, Tehran, Iran.
2.2. Mutation detection
Genomic DNA was extracted from peripheral blood of the
family members following the standard salting out procedure
[18]. At ﬁrst step, GJB2 was screened for c.35delG mutation using
allele-speciﬁc PCR ampliﬁcation (ARMS PCR) with primers as
described by Scott et al. [19]. No further testing was done on
homozygote individuals for the 35delG allele variant of GJB2,
and in this group, the diagnosis of DFNB1 deafness was made. In
normal ones for the 35delG allele, the entire exons 1 and 2 were
later sequenced for other allele variants using Big Dye
Terminators (Applied Biosystems 3130 Genetic Analyzer).
Probands who were negative or only have one GJB2 mutated
allele were analyzed for the presence of the del(GJB6-D13S1830)
and del(GJB6-D13S1854) of the GJB6 gene as described by del
Castillo et al. [14].Fig. 1. One family’s pedigree with novel identiﬁed mutation3. Results
13 out of 50 Iranian families presenting ARNSHL from Ardabil
province in Northwestern of Iran, showed mutations in the GJB2
gene (26%) (Table 1). Homozygous 35delG mutation was observed
in 9 families, accounting for 69.2% of the GJB2 mutations in this
ethnic group. Other detected mutations were delE120 and 299–
300delAT, each in one family. A novel c.463–464delTA mutation
was also observed in two families (Fig. 1). This mutation causes a
frame shift mutation at codon 155 followed by a stop codon at 208
which resulting to a truncated protein.
We also could identify A171T and V27I+E114G variants in
heterozygote form. No mutation was detected in exon 1.
Screening for the two GJB6 deletions did not reveal a positive
sample among GJB2 negative or heterozygote samples.
4. Discussion
Deafness related to DFNB1 locus is the most common cause of
ARNSD in many countries throughout the world [4,20]. Based on
extreme heterogeneity of autosomal recessive non syndromic
hearing Loss, study of diverse ethnic groups are necessary to
establish the frequency of different genes involved in HL and
specially GJB2 mutations as a cause of hearing impairment. The
frequency of mutations may vary between countries or even
within different ethnic groups of a particular country. For example,
the prevalence of GJB2 mutations in Slovakia is 45.6 [21], France
39.8 [22], Turkey 25% [23], Pakistan 6.1% [24] and 0% in Oman [25].
The Iranian population is composed of many different ethnic
groups, so it is important to generate ethnic speciﬁc data.
The study performed by Najmabadi et al. [14] indicated that
GJB2 related deafness account for 16.7% in Iranian population and
35delG mutation was the most common deafness-causing allele,
occurring in 71.6% of persons with DFNB1 deafness. They also
found the highest percentage of GJB2-related deafness in the north and segregation of the c.463–464delTA in this family.
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demonstrating a gradual decrease in the frequency of 35delG
mutation and deafness caused by GJB2 gene from northwest to
south-east of Iran.
In another study, Hashemzadeh et al. [15] showed that there is a
rate of about 27.5% of GJB2 mutations in the north and Northwest
of the Iran, but a very low rate of about 4% in the south and south
east.
Bonyadi et al. [26] presented that GJB2 mutations are
responsible for about 28% of the autosomal recessive nonsyn-
dromic hearing loss in the Iranian Azeri Turkish patients and
35delG is the most prevalent mutation accounting for 64.5% of
patient with GJB2 impairment.
Given the high frequency of 35delG in north and northwest of
Iran [14,15] and by studying ﬂanking polymorphisms, Norouzi
et al. [27] investigated the origination of 35delG mutation from
somewhere in north and northwest of Iran.
The families represented in this study are located in the
Northwest part of Iran. According to previous described results, we
expected the high level of contribution of GJB2 mutation in this
ethnic group. Our presented data here conﬁrm the importance of
GJB2 mutations in this ethnic group. We found that the
contribution of the GJB2 gene in nonsyndromic autosomal
recessive hearing loss in Ardebil province was 26% and the most
common mutation was 35delG, which is similar with those
reported by Najmabadi et al. [14] and Hashemzadeh et al. [15].
Since Turkey is the Northwest neighboring country of Iran, we
expected the similar frequency ratio of different genes. In one
study from Turkey, Kalay et al. [23] showed that the GJB2 gene
mutations result in approximately 25% of autosomal recessive
nonsyndromic hearing losses. Furthermore, it was reported that
GJB2 mutations are responsible for about 22% of cases of deafness
in Turkey [28].
In our study, homozygote delE120 mutation was found in one
family (1/50). According to previously reported studies, 35delG
and delE120 are the ﬁrst and second most common mutations in
Turkey [28,29] which is in compliance with our data.
Besides, we could identify homozygote 299–300delAT muta-
tion in one family. This mutation was ﬁrst described by Abe et al. in
2000 as a heterozygote variant related to HI [30]. Two years later
Wang et al., found this mutation in homozygote form in a patient
suggesting it as a HI associated, recessive inherited GJB2 mutation
[31]. This mutation has been described as disease associated with a
recessive mode of inheritance in Turkey [32] and in Iran
(Bazazzadegan et al., ahead of submit).
Both of V27I (c.79G > A) and E114G (c.341G > A) are very
common in the East Asian population [30,33]. Pandya et al.
suggested that when these two changes present together in cis-
conﬁguration, homozygous V27I+E114G or compound heterozy-
gote with another mutation can cause hearing loss [34]. Lately, in
order to investigate the pathogenesis of V27I and E114G variants,
Choi et al. used in vitro assay and population study and indicated
that E114G variant is deleterious but V27I+E114G represent a non
pathogenic polymorphism and suggest that only E114G homozy-
gote or compound heterozygote carrying E114G type with other
mutations may cause HL [35]. In our study, V27I+E114G/wt
genotype was found so the cause of hearing loss in this family is
still unknown.
A171T variant was ﬁrst identiﬁed in Korean population by Lin
et al. [36]. This is an unknown variant which is located in
extracellular domain 2 of the CX26 protein [6]. We found the
A171T in heterozygote form. Sequencing of exon1 and GJB6 did not
detect any other mutated allele.
One novel mutation (c.463–464delTA) was identiﬁed in 2
families (2/50) affected with DFNB1 deafness in this study. This
mutation is located in the second extracellular domain [37] ofconnexin26 and leads to a frame shift mutation and formation of a
premature stop codon at amino acid position 208 of the
connexin26 gene [p.(Y155CfsX54)]. This novel mutation in Cx26
sounds as a common cause of deafness in this part of Iran and
mutation screening of GJB2 for c.463–464delTA in all persons with
hearing loss who originate from this geographic region should be
mandatory.
According to previous studies, no del(GJB6-D13S1830) and
del(GJB6-D13S1854) have been detected in Iranian populations
[14,38]. This is in agreement with our results and suggests that it
may have no role in pathogenesis of ARNSHL in Azeri population.
In conclusion, our data support the view that speciﬁc
combinations of GJB2 mutation exist in different populations
and 35delG is the main pathogenic mutation site in GJB2 gene in
Iranian Azeri population. The incidence of this mutation among
Azeri ethnic group is higher than the average level of the general
Iranian deaf population.
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